Home Stocks Alkem Laboratories Ltd

Alkem Laboratories Ltd

The live share price of Alkem Laboratories Ltd (ALKEM) as on 26 Apr 6:52am is ₹4,900.15 from NSE/BSE.

ALKEM NSE

₹4,900.15 ▲0.67% (32.5)

As on Apr 26, 2024 12:22 PM IST

How do you feel today about Alkem Laboratories Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

36.99

PB Ratio

6.17

Dividend Yield

1.03%

Sector PB

5.94

Sector PE

52.96

Sector Div Yld

0.54%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹58,200 Cr

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

The following charts display the financial performance of the Alkem Laboratories Ltd (ALKEM) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Alkem Laboratories Ltd (ALKEM), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹58,200 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	11,815 Cr	+9.43%
Operating Expense	1,189 Cr	+3549.34%
Net Income	984 Cr	-40.19%
Net Profit Margin	8.33%	-45.34%
Earning Per Share	82	-40.2%
EBITDA	1,722 Cr	-21.72%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	2,934 Cr	+7.96%
Total Assets	13,756 Cr	-2.22%
Total Liabilities	4,321 Cr	-17.24%
Total Equity	9,435 Cr	+6.64%
Shares Outstanding	11.96 Cr	+0.03%
Price to Book	4.3	-8.91%
Return on Assets	7.07%	-45.02%
Return on Capital	14.97 Cr	-30.18%

Cash Flows

(INR)		Y/Y Change
Net Income	984 Cr	-40.19%
Cash from Operations	1,682 Cr	+51.44%
Cash from Investing	119 Cr	-108.37%
Cash from Financing	-1,760 Cr	-563.9%
Net Change in Cash	41 Cr	-28.19%
Free Cash Flow	1,449 Cr	+87.74%

Shareholding Pattern

Total Promoter Holding

56.74%

Unpledged

Foreign Institutions

9.11%

Foreign Institutions

Retail & Others

18.52%

Retail & Others

Other Parties

Other Domestic Institutions

3.71%

Insurance Firms

Others

Mutual Funds

11.92%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

40.95

1Y Return

▲56.31%

CIPLA

Cipla Ltd

PE Ratio

30.62

1Y Return

▲54.59%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

19.81

1Y Return

▲28.66%

MANKIND

Mankind Pharma Ltd

PE Ratio

55.63

1Y Return

▲68.64%

Latest News

Alkem Laboratories sinks 3 percent on US FDA’s 10 observations for Himachal unit

4 weeks ago on Moneycontrol

Change since news ▼-INF%

After the US FDA inspection, Alkem Laboratories has received Form 483 with 10 observations for its Baddi plant.

Trade setup for Thursday: 15 things to know before opening bell

4 weeks ago on Moneycontrol

Change since news ▼-INF%

Based on the OI percentage, 65 stocks saw long unwinding, which included Alkem Laboratories, HDFC AMC, Voltas, Ipca Laboratories and MRF

Trade setup for Friday: 15 things to know before opening bell

2 months ago on Moneycontrol

Change since news ▼-INF%

Based on the OI percentage, 130 stocks were on the short-covering list. This included Sun Pharmaceutical Industries, Samvardhana Motherson International, Alkem Laboratories, Zydus Lifesciences, and Bata India.

FAQs on Alkem Laboratories Ltd

How to buy Alkem Laboratories Ltd stocks?

You can easily buy the stocks/shares of Alkem Laboratories Ltd (ALKEM) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Alkem Laboratories Ltd?

The stock price of Alkem Laboratories Ltd as on 26 Apr 2024 is ₹4,900.15

What is the 52-week High and Low of Alkem Laboratories Ltd?

The 52-week high and low of Alkem Laboratories Ltd (ALKEM) is ₹5,520 and ₹3,186.3.

What is the PE and PB ratio of Alkem Laboratories Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Alkem Laboratories Ltd are 36.99 and 6.17 respectively.

What are the peers or stocks similar to Alkem Laboratories Ltd?

The peers or stocks similar to Alkem Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Alkem Laboratories Ltd belong to?

Alkem Laboratories Ltd (ALKEM) belongs to the Pharmaceuticals sector.

What is the Market Cap of Alkem Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alkem Laboratories Ltd (ALKEM) is ₹58,200 Cr as of 26 Apr 2024

Can't decide whether or not to buy Alkem Laboratories Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.